Niamh Louise Pellegrini Insider Trading $NVRO NEVRO CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Niamh Louise Pellegrini.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Niamh Louise Pellegrini. Niamh Louise Pellegrini is President, North America in THORATEC CORP ($THOR) and Chief Commercial Officer in NEVRO CORP ($NVRO).
Niamh Louise Pellegrini in NEVRO CORP
Trading Symbol: NVROIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Niamh Louise Pellegrini: Chief Commercial Officer
Holdings: 39,968 shares
Current Value: $3,730,213
Latest Transaction: Mar 12 2021
$NVRO Market Capitalization: $2.71B
$NVRO Previous Close: $93.33
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Niamh Louise Pellegrini in NEVRO CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2021 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Option Exercise | M | 64.95 | 750 | 48,713 | 65,575 | |
Mar 12 2021 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Sell | S | 148.08 | 750 | 111,060 | 39,218 | 40 K to 39.2 K (-1.88 %) |
Mar 12 2021 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Buy | M | 64.95 | 750 | 48,713 | 39,968 | 39.2 K to 40 K (+1.91 %) |
Mar 04 2021 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Payment of Exercise | F | 168.11 | 706 | 118,686 | 39,218 | 39.9 K to 39.2 K (-1.77 %) |
Mar 04 2021 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Grant | A | 0.00 | 9,596 | 0 | 39,924 | 30.3 K to 39.9 K (+31.64 %) |
Feb 12 2021 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Option Exercise | M | 64.95 | 750 | 48,713 | 66,325 | |
Feb 12 2021 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Sell | S | 182.55 | 750 | 136,913 | 30,328 | 31.1 K to 30.3 K (-2.41 %) |
Feb 12 2021 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Buy | M | 64.95 | 750 | 48,713 | 31,078 | 30.3 K to 31.1 K (+2.47 %) |
Jan 13 2021 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Option Exercise | M | 64.95 | 750 | 48,713 | 67,075 | |
Jan 13 2021 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Sell | S | 169.80 | 750 | 127,350 | 30,328 | 31.1 K to 30.3 K (-2.41 %) |
Jan 13 2021 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Buy | M | 64.95 | 750 | 48,713 | 31,078 | 30.3 K to 31.1 K (+2.47 %) |
Dec 14 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Option Exercise | M | 64.95 | 750 | 48,713 | 67,825 | |
Dec 14 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Sell | S | 160.72 | 450 | 72,322 | 30,328 | 30.8 K to 30.3 K (-1.46 %) |
Dec 14 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Sell | S | 161.96 | 300 | 48,588 | 30,778 | 31.1 K to 30.8 K (-0.97 %) |
Dec 14 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Buy | M | 64.95 | 750 | 48,713 | 31,078 | 30.3 K to 31.1 K (+2.47 %) |
Nov 12 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Option Exercise | M | 64.95 | 750 | 48,713 | 68,575 | |
Nov 12 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Sell | S | 170.75 | 750 | 128,063 | 30,328 | 31.1 K to 30.3 K (-2.41 %) |
Nov 12 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Buy | M | 64.95 | 750 | 48,713 | 31,078 | 30.3 K to 31.1 K (+2.47 %) |
Oct 26 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Sell | S | 165.00 | 1,817 | 299,805 | 30,328 | 32.1 K to 30.3 K (-5.65 %) |
Oct 21 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Sell | S | 155.00 | 1,000 | 155,000 | 32,145 | 33.1 K to 32.1 K (-3.02 %) |
Oct 13 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Option Exercise | M | 64.95 | 750 | 48,713 | 69,325 | |
Oct 13 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Sell | S | 151.47 | 750 | 113,603 | 33,145 | 33.9 K to 33.1 K (-2.21 %) |
Oct 13 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Buy | M | 64.95 | 750 | 48,713 | 33,895 | 33.1 K to 33.9 K (+2.26 %) |
Oct 13 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Sell | S | 150.00 | 1,000 | 150,000 | 33,145 | 34.1 K to 33.1 K (-2.93 %) |
Sep 14 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Option Exercise | M | 64.95 | 750 | 48,713 | 70,075 | |
Sep 14 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Sell | S | 139.14 | 750 | 104,355 | 34,145 | 34.9 K to 34.1 K (-2.15 %) |
Sep 14 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Buy | M | 64.95 | 750 | 48,713 | 34,895 | 34.1 K to 34.9 K (+2.20 %) |
Aug 10 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Option Exercise | M | 64.95 | 750 | 48,713 | 70,825 | |
Aug 10 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Sell | S | 140.11 | 750 | 105,083 | 34,145 | 34.9 K to 34.1 K (-2.15 %) |
Aug 10 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Buy | M | 64.95 | 750 | 48,713 | 34,895 | 34.1 K to 34.9 K (+2.20 %) |
Aug 10 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Payment of Exercise | F | 141.77 | 4,476 | 634,563 | 34,145 | 38.6 K to 34.1 K (-11.59 %) |
Mar 04 2020 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Grant | A | 0.00 | 5,446 | 0 | 38,621 | 33.2 K to 38.6 K (+16.42 %) |
Jul 17 2019 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Option Exercise | A | 64.95 | 71,575 | 4,648,796 | 71,575 | |
Jul 17 2019 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Grant | A | 0.00 | 33,175 | 0 | 33,175 | 0 to 33.2 K |
Page: 1